Premier Research

We’re excited to announce that we’re enhancing our hiring process with a new and improved Applicant Tracking System (ATS)! This change reflects our commitment to creating a seamless, efficient, and transparent experience for our candidates. If you previously applied to an open position at Premier, you’ll need to create a new account to apply for future roles. If you have existing job alerts, you have to re-create those alerts in the new system. Create your account here: https://bit.ly/3NVPSXz Here’s to finding and welcoming new Premier team members!

What do you know about logic-gating? This sophisticated bioengineering strategy holds significant promise. But how exactly can it enhance safety, efficacy, and precision in CAR-T therapy? Find out: https://bit.ly/4fbuhq7 #CARTcelltherapies #CARTcelltherapy #Oncology #OncologyTrials

Putting toxicology at the forefront, join us at the ACT Annual Meeting! We’ll be at Booth #510, serving as a hub for networking + learning as we chart the course for innovation in the field! https://bit.ly/3NQ5mMJ William Salminen, PhD, DABT, RAC, PMP, Vice President of Regulatory Toxicology and Clinical Pharmacology, will be co-chairing and speaking at the symposium. #Toxicology #ACTOX2024

Our neuroscience team is excited to be attending CNS Summit! Connect with us to discover how leveraging our expertise can help bring your breakthrough therapies to patients in need. https://bit.ly/3YwfDT4 Krista Armstrong, Adam Simmons, Andreas Schreiner, Laurie Willis, Thomas Laage, MD, MPH, Sofie Reynders, MSHS, MS, MBA #CNSSummit #Neuroscience #ClinicalResearch #DrugDevelopment

What medical conditions affect 70 million people, yet urgency to find and fund a cure is low? It’s not a trick question. Our case study explores how we helped "find a voice" for patients with a previously untreated dermatological condition: https://lnkd.in/e58bTS_E #Dermatology #ClinicalResearch #ClinicalTrials

England is doing something unique and incredible – the genetic code of up to 100,000 newborn babies will be analyzed by the NHS. The goal? Speeding up the diagnosis and treatment of 200+ rare diseases! https://bbc.in/3NLT2wQ #RarePediatricDisease #RareDiseases

Healthcare has counted on lab developed tests for decades. Now, the FDA is moving toward a more structured regulatory approach, with new requirements for labs. Here’s what you need to know: https://bit.ly/3YF9QvL #LDTs #FDA #RegulatoryConsiderations #FDARequirements

Don’t settle. Ensure timely recruitment, high quality data, and study success by leveraging 6 key data sources for smarter site selection! Find out how we did it in Spain: https://bit.ly/3UtVI6d #SiteSelection #ClinicalTrialSiteSelection #ClinicalResearch

When it comes to psychedelic drugs, you need an expert who really knows what they’re talking about. Carlos Langezaal and Andreas Schreiner, fit the bill. Get their perspectives and guidance: https://bit.ly/3C5g7YE Carlos Langezaal, PhD, Senior Director, Regulatory Affairs has over 30 years of drug development experience driving global regulatory strategy to achieve development goals and business objectives. Andreas Schreiner, MD, Senior Vice President, Medical Affairs, Neuroscience & Analgesia, is a board certified psychiatrist and neurologist with over 23 years of global experience within the pharma industry and clinical research. #webinar #Psychedelics #PsychedelicDrugs #PsychiatryStudies #RegulatoryGuidance

Hola, Barcelona! Attending SCOPE EU? Join our presentation with our own Nicole Stansbury who will be co-presenting the TransCelerate Solutions Framework for effective risk-based quality management! https://bit.ly/3NruNUr #SCOPEEU #ClinicalResearch #RBQM